Intas Pharmaceuticals
Shailesh Bharti is an experienced professional in the field of biotechnology and bioprocess technology. Currently serving as an Associate Scientist at Intas Pharmaceuticals since March 2024, Shailesh previously held the position of Senior Scientist at Biocon Biologics from September 2021 to March 2024 and worked as an Executive Officer at Serum Institute of India Pvt. Ltd. from November 2020 to September 2021. Earlier experience includes an internship at Biocon in 2019, where Shailesh gained hands-on experience in a mammalian downstream lab. Educational qualifications include a Master of Technology in Bioprocess Technology from the Institute of Chemical Technology, and a Master of Technology in Chemical Engineering from Dr. B R Ambedkar National Institute of Technology, along with a Bachelor of Technology in Biotechnology from Sardar Vallabh Bhai Patel University of Agriculture and Technology. Shailesh completed education from Jawahar Navodaya Vidyalaya from 2006 to 2012.
This person is not in the org chart
Intas Pharmaceuticals
2 followers
Intas Pharmaceuticals Ltd. is an India-based pharmaceutical formulation development, manufacturing and marketing company. The Company offers products for the treatment of cardiovascular system (CVS), diabetology, gynecology, infertility, respiratory care, gastroenterology, pain management, as well as other therapeutic segments. Its pharma products include ACUTROL-400, ADAPEN GEL, ADIFLOX, ALZIL 10, ALZIL M 10 and AMITONE 10. The Company's biologics products include Albucel 20%, Epofit, Erykine, Factocel VIII, MabTas, Neukine and Neupeg. It range of products for animal health includes AC-Vet, AC-Vet Forte, AC-Vet Max, Alzonic, Anistamin, Benezepril, Bufzone, Calshakti Platina and Carprofen Inj. The Company offers approximately 10 biologic products and is engaged in research and development in chronic disease areas, such as oncology (cancer), rheumatology, auto-immune, nephrology, ophthalmology and plasma derived product based therapies.